Lisa Bright is President at INTERCEPT PHARMACEUTICALS, INC. (ICPT). They have made 27 open-market trades across 1 company since 2015, most recently 2020-07-01.
CIK 0001635111
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 27 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICPT | 22,012 | $418K |
Shares reported on the most recent Form 4, priced at the 2020-07-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICPT | SELL · 10b5-1 | 2019-10-29 | 2019-10-31 | $75.00 | $45K | +13.7% | +53.8% | +28.1% |
| ICPT | SELL · 10b5-1 | 2019-07-03 | 2019-07-03 | $78.66 | $47K | -13.8% | -21.2% | -17.3% |
| ICPT | SELL | 2019-04-03 | 2019-04-03 | $115.01 | $137K | -19.8% | -21.8% | -31.6% |
| ICPT | SELL | 2019-01-07 | 2019-01-09 | $104.93 | $276K | -1.0% | +6.1% | +5.6% |
| ICPT | SELL | 2018-12-03 | 2018-12-06 | $111.42 | $557K | +0.0% | +2.9% | -2.1% |
| ICPT | SELL | 2017-10-02 | 2017-10-04 | $58.92 | $23K | -2.6% | -5.9% | -18.5% |
| ICPT | SELL | 2017-08-25 | 2017-08-29 | $111.31 | $28K | +0.7% | -48.9% | -47.6% |
| ICPT | SELL | 2017-08-02 | 2017-08-02 | $110.29 | $16K | -0.7% | +12.6% | -41.6% |
| ICPT | SELL | 2017-07-03 | 2017-07-05 | $121.33 | $48K | +1.6% | -12.9% | -46.6% |
| ICPT | SELL | 2017-06-01 | 2017-06-02 | $110.73 | $77K | +1.3% | +1.7% | -3.0% |
| ICPT | SELL | 2017-05-25 | 2017-05-30 | $117.52 | $30K | +6.5% | +12.1% | +2.3% |
| ICPT | SELL | 2017-05-16 | 2017-05-18 | $119.75 | $14K | -3.8% | +8.2% | -9.3% |
| ICPT | SELL | 2017-05-02 | 2017-05-10 | $114.00 | $49K | -1.6% | +1.0% | -8.0% |
| ICPT | SELL | 2017-04-03 | 2017-04-05 | $115.00 | $45K | -2.8% | +8.1% | +13.2% |
| ICPT | SELL | 2017-03-02 | 2017-03-06 | $130.16 | $342K | -0.1% | -12.8% | -3.5% |
| ICPT | SELL | 2017-03-01 | 2017-03-03 | $130.16 | $18K | -0.1% | -11.1% | -10.2% |
| ICPT | SELL | 2017-02-27 | 2017-03-01 | $119.48 | $30K | -2.5% | -13.7% | -17.2% |
| ICPT | SELL | 2017-01-31 | 2017-02-02 | $108.96 | $15K | +17.2% | +16.3% | +4.0% |
| ICPT | SELL | 2017-01-03 | 2017-01-05 | $103.92 | $233K | +9.5% | +6.5% | +3.4% |
| ICPT | SELL | 2016-11-25 | 2016-11-29 | $113.60 | $28K | +1.5% | +4.6% | +19.6% |
| ICPT | SELL | 2016-11-15 | 2016-11-17 | $112.27 | $16K | -12.7% | -5.1% | +14.7% |
| ICPT | SELL | 2016-10-03 | 2016-10-05 | $163.20 | $25K | -9.3% | -35.9% | -32.6% |
| ICPT | SELL | 2016-08-25 | 2016-08-25 | $159.00 | $39K | -0.6% | +7.8% | -25.8% |
| ICPT | SELL | 2016-07-05 | 2016-07-07 | $145.11 | $22K | +1.4% | +12.6% | +7.4% |
| ICPT | SELL | 2016-05-25 | 2016-05-26 | $137.50 | $35K | +15.1% | -6.6% | +13.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.